Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo

Phytotherapy Research

Volumn 23, Issue 5, 2009, Pages 677-686

  Hong, Si Jia ^a   Wan, Jian Bo ^a   Zhang, Yi ^a   Hu, Guang ^a   Lin, Hui Chao ^a   Sai, Wang Seto ^b   Kwan, Yiu Wa ^b   Lin, Zhi Xiu ^b   Wang, Yi Tao ^a   Lee, Simon Ming Yuen ^a  

^a University of Macau   (Macao)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiogenesis; KDR Flk 1; PI3K AKT eNOS; Saponin extract from Panax notoginseng (PNS)

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B INHIBITOR; SAPONIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANGIOGENIC FACTOR; NOS3 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHINESE MEDICINE; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; NONHUMAN; PANAX NOTOGINSENG; POLYMERASE CHAIN REACTION; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; ENDOTHELIUM CELL; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

DANIO RERIO; MUS; PANAX NOTOGINSENG;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EMBRYO, NONMAMMALIAN; ENDOTHELIAL CELLS; HUMANS; MICE; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PANAX NOTOGINSENG; PLANT EXTRACTS; SAPONINS; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH;

EID: 65649110072     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2705     Document Type: Article

References (51)

1. Ahmad S, Hewett PW, Wang P et al. 2006. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 99: 715-722.
2. Aiello LP, Avery RL, Arrigg PG et al. 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 22: 1480-1487.
3. Amano M, Suzuki M, Andoh S et al. 2007. Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay. Int J Clin Oncol 12: 42-47.
4. Bocci G, Danesi R, Marangoni G et al. 2004a. Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine. Eur J Pharmacol 498: 9-18.
5. Bocci G, Man S, Green SK et al. 2004b. Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. Cancer Res 64: 6616-6625.
6. Boo YC, Hwang J, Sykes M et al. 2002. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 283: 1819-1828.
7. Bussolati B, Dunk C, Grohman M et al. 2001. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159: 993-1008.
8. Cai J, Jiang WG, Ahmed A et al. 2006. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71: 20-31.
9. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
10. Dimmeler S, Zeiher AM. 1999. Nitric oxide - an endothelial cell survival factor. Cell Death Differ 10: 964-968.
11. Dong TX, Cui XM, Song ZH et al. 2003. Chemical assessment of root of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem 51: 4617-4623.
12. Du XW, Liu Y, Li B. 2005. Understanding traditional application of ginseng, American ginseng and notoginseng from the way of chemical constituents and pharmacological effects. Acta Chin Med Pharmacol. 4: 66-69.
13. Fan TP, Yeh JC, Leung KW et al. 2006. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 27: 297-309.
14. Ferrera N. 1999. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543.
15. Folkman J. 1999. Angiogenesis research: from laboratory to clinic. Forum (Genova) 9: 59-62.
16. Fulton D, Gratton JP, McCabe TJ et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601.
17. Furukawa T, Bai CX, Kaihara A et al. 2006. Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a congenomic pathway of sex hormones. Mol Pharmacol 70: 1916-1924.
18. Gille H, Kowalski J, Li B et al. 2001. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 276: 3222-3230.
19. Grzelec-Mojzesowicz M, Sadowski J. 2007. Renal tissue NO and intrarenal haemodynamics during experimental variations of NO content in anaesthetised rats. J Physiol Pharmacol 58: 149-163.
20. Harris MB, Ju H, Venema VJ et al. 2001. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276: 16587-16591.
21. Huang YC, Chen CT, Chen SC et al. 2005. A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharm Res 22: 636-646.
22. Isner JM. 1998. Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. Adv Drug Deliv Rev 30: 185-197.
23. Kiselyov A, Balakin KV, Tkachenko SE et al. 2007. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opin Investig Drugs 16: 83-107.
24. Kwan TT, Liang R, Verfaillie CM et al. 2006. Regulation of primitive hematopoiesis in zebrafish embryos by the death receptor gene. Exp Hematol 34: 27-34.
25. Lam HW, Lin HC, Lao SC et al. 2008. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. J Cell Biochem 103: 195-211.
26. Lee JY, Chung E, Kwang YL et al. 1997. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol 133: 135-140.
27. Lee K, Wang H, Itokawa H et al. 2000. Current perspective on Chinese medicines and dietary supplements in China, Japan, and the United States. J Food Drug Anal 8: 219-228.
28. Leung KW, Cheng YK, Mak NK et al. 2006. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 580: 3211-3216.
29. Leung KW, Pon LY, Wong NS et al. 2006. Ginsenoside-Rg1 induces vascular endothelial growth factor expression though the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and β-catenin/T-cell factor-dependent pathway in human endothelial cells. J Biol Chem 281: 36280-36288.
30. Lewy-Trenda I. 2002. Neoplasms and angiogenesis. Pol Merkur Lekarski 13: 225.
31. Mariella F. 2000. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113: 59-69.
32. Mario AE, Sandra A, Diana V et al. 2008. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Invest Ophthalmol Vis Sci 49: 2337-2342.
33. Milkiewicz M, Hudlicka O, Brown MD et al. 2005. Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 289: H336-H343.
34. Mitchell CA, Risau W, Drexler HC. 1998. Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium. Dev Dyn 213: 322-333.
35. Mochizuki M, Yoo YC, Matsuzawa K et al. 1995. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside- Rg3, of red ginseng. Biol Pharm Bull 18: 1197-1202.
36. Morales-Ruiz M, Lee MJ, Zollner S et al. 2001. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis though a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276: 19672-19677.
37. Schor AM, Ellis I, Schor SL. 2001. Collagen gel assay for angiogenesis. In Methods in Molecular Medicine, Vol. 46: Angiogenesis Protocols, Murray JC (ed.). Humana Press, Inc.: Totowa, NJ, 145-162.
38. Seng WL, Eng K, Lee J et al. 2004. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Angiogenesis 7: 243-253.
39. Sengupta S, Sellers LA, Li RC et al. 2003. Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation 107: 2955-2961.
40. Sengupta S, Toh SA, Sellers LA et al. 2004. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110: 1219-1225.
41. Shin HR, Kim JY, Yun TK et al. 2000. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 11: 565-576.
42. Tanimoto T, Jin ZG, Berk BC. 2002. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277: 42997-43001.
43. Tímár J, Döme B, Fazekas K et al. 2001. Angiogenesis: dependent diseases and angiogenesis therapy. Pathol Oncol Res 7: 85-94.
44. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
45. Wan JB, Lai CM, Li SP et al. 2006a. Simultaneous determination of nine saponins from Panax notoginseng using HPLC and pressurized liquid extraction. J Pharm Biomed Anal 41: 274-279.
46. Wan JB, Li SP, Chen JM et al. 2007. Chemical characteristics of thee medicinal plants of the Panax genus determined by HPLC-ELSD. J Agric Food Chem 51: 4617-4623.
47. Wan JB, Li P, Li SP et al. 2006b. Simultaneous determination of 11 saponins in Panax notoginseng using HPLC-ELSD and pressurized liquid extraction. J Sep Sci 29: 2190-2196.
48. Wan JB, Li SP, Wang YT. 2006c. Chemical characteristics of different parts from Panax notoginseng by HPLC-ELSD. J Pharm Biomed Anal 41: 1596-1601.
49. Xin X, Liu J, Li X et al. 2006. Extraction of 20(S)-ginsenoside Rg2 from cultured Panax notoginseng cells in vitro stimulates human umbilical cord vein endothelial cell proliferation. Am J Ther 13: 205-210.
50. Yu LC, Chen SC, Chang WC et al. 2007. Stability of angiogenic agents, ginsenoside Rg1 and Re, isolated from Panax ginseng: In vitro and in vivo studies. Int J Pharm 328: 168-176.
51. Yue PY, Wang YL, Wu PK et al. 2006. The angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem Pharmacol 72: 437-445.